<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05105204</url>
  </required_header>
  <id_info>
    <org_study_id>N202106030</org_study_id>
    <nct_id>NCT05105204</nct_id>
  </id_info>
  <brief_title>ArteVu Blood Pressure Accuracy Study</brief_title>
  <acronym>ARTEVU</acronym>
  <official_title>ArteVu Blood Pressure Accuracy Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cardio Ring Technologies, Inc. Taiwan Branch</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cardio Ring Technologies, Inc. Taiwan Branch</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A continuous noninvasive blood pressure monitoring digital fingertip clip device, the ArteVu,&#xD;
      will be compared against the reference arterial catheter during operation. The device safety&#xD;
      and its blood pressure accuracy will be examined in the study.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      ArteVu is a non-invasive and continuous blood pressure monitor. It detects the arterial&#xD;
      pressure waveform with a force sensor that detects the arterial pulsation that produces&#xD;
      changes in pressure transmitted through the subcutaneous tissue overlying or adjacent to the&#xD;
      digital arteries. The data is transmitted to a parameter module to display noninvasive and&#xD;
      continuous blood pressure in a hospital setting. The primary objective of this study is to&#xD;
      validate ArteVu's blood pressure and heart rate measurement accuracy by comparing its values&#xD;
      simultaneously with the corresponding values obtained from an invasive radial arterial line.&#xD;
      The secondary objective is to evaluate the effectiveness of utilizing ArteVu for continuous&#xD;
      blood pressure measurements. The study population includes 50 patients undergoing surgery who&#xD;
      requires general anesthesia and continuous blood pressure measurement with a radial arterial&#xD;
      line. Blood pressure values measured from the arterial line will be recorded simultaneously&#xD;
      during ArteVu's measurements.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 14, 2021</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Days</target_duration>
  <primary_outcome>
    <measure>Blood pressure and heart rate measurement accuracy</measure>
    <time_frame>around two hours.</time_frame>
    <description>To validate ArteVu's blood pressure and heart rate measurement accuracy by comparing its values simultaneously with the corresponding values obtained intra-arterially from an invasive radial arterial line, meeting a bias (as measured by overall mean difference) less than 5 mmHg and a standard deviation less than 8 mmHg for systolic and diastolic blood pressure. This accuracy satisfies the limits established for the validation of automatic blood pressure measurement according to the ANSI/AAMI/ISO 81060-2 standard.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Blood Pressure</condition>
  <arm_group>
    <arm_group_label>Individuals need intra-arterial catheter at the radial artery for blood pressure monitoring</arm_group_label>
    <description>Individuals who requiring the use of intra-arterial catheter at the radial artery for continuous blood pressure monitoring for at least two hours as part of their planned care.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ArteVu</intervention_name>
    <description>The study participants will concurrently undergo noninvasive blood pressure monitoring with the ArteVu finger clip applied to the same extremity that is being used to measure the radial artery pressure.</description>
    <arm_group_label>Individuals need intra-arterial catheter at the radial artery for blood pressure monitoring</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patient enrollment will continue until at least 30% are male; 30% are female; at least 40 %&#xD;
        patients have a limb circumference that lies within the upper half of 22-32 cm; at least 40&#xD;
        % are within the lower half of 22-32 cm; in addition, 50 complete one-hour CNBP and NBP&#xD;
        data sets are obtained. To assure that a sufficient range of blood pressure values are&#xD;
        obtained, at least 10% of the measurements shall have invasive reference systolic blood&#xD;
        pressure(SBP) lower or equal to 100 mmHg. At least 10% of the measurements shall have&#xD;
        invasive reference SBP higher or equal to 160 mmHg. At least 10% of the measurements shall&#xD;
        have invasive reference diastolic blood pressure(DBP) lower or equal to 70mmHg. At least&#xD;
        10% of the measurements shall have invasive reference DBP higher or equal to 85 mmHg.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥ 20 years&#xD;
&#xD;
          2. Requiring general anesthesia and continuous blood pressure measurement with a radial&#xD;
             arterial line&#xD;
&#xD;
          3. Limb circumference is within 22 cm - 32 cm&#xD;
&#xD;
          4. The width of the first knuckle of the index/middle/Ring finger is less than 19.8 mm&#xD;
&#xD;
          5. Ease of access to the finger and arm used for ArteVu&#xD;
&#xD;
          6. Able to provide written informed consent for participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant patients&#xD;
&#xD;
          2. Medical or surgical condition that prevents the ability to apply the ArteVu device on&#xD;
             an upper extremity finger or the ipsilateral arm such as impaired skin integrity&#xD;
&#xD;
          3. Operations involving the upper extremities or the blood vessels of the upper&#xD;
             extremities&#xD;
&#xD;
          4. Arthritis or severe deformities of the hand and fingers&#xD;
&#xD;
          5. Prosthetic devices or jewelry that cannot be removed from the finger or the&#xD;
             ipsilateral arm to be used for the ArteVu device&#xD;
&#xD;
          6. History of malignant hyperthermia&#xD;
&#xD;
          7. Raynaud's disease affecting the fingers or hands&#xD;
&#xD;
          8. Topical allergy to Acrylonitrile Butadiene Styrene(ABS), Polycarbonate(PC), or&#xD;
             silicone&#xD;
&#xD;
          9. Swelling, edema or lymphedema of the upper extremity&#xD;
&#xD;
         10. Participants with upper extremity occlusive peripheral vascular diseases&#xD;
&#xD;
         11. Inability of the patient to provide written informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chuen-Chau Chang, M.D,PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taipei Medical University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leng-Chun Chen, PhD</last_name>
    <phone>+886933220322</phone>
    <email>rubychen@cardioring.co</email>
  </overall_contact>
  <location>
    <facility>
      <name>Taipei Medical University Hospital</name>
      <address>
        <city>Taipei City</city>
        <zip>11031</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chuen-Chau Chang, M.D,PhD</last_name>
      <phone>+886227372181</phone>
      <phone_ext>8420</phone_ext>
      <email>nekota@tmu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <link>
    <url>https://www.iso.org/standard/73339.html</url>
    <description>Association for the Advancement of Medical Instrumentation. Non-invasive sphygmomanometers-Part 2: Clinical investigation of intermittent automated measurement type. This is also a results reference.</description>
  </link>
  <reference>
    <citation>Williams JS, Brown SM, Conlin PR. Videos in clinical medicine. Blood-pressure measurement. N Engl J Med. 2009 Jan 29;360(5):e6. doi: 10.1056/NEJMvcm0800157.</citation>
    <PMID>19179309</PMID>
  </reference>
  <reference>
    <citation>Stenglova A, Benes J. Continuous Non-Invasive Arterial Pressure Assessment during Surgery to Improve Outcome. Front Med (Lausanne). 2017 Nov 17;4:202. doi: 10.3389/fmed.2017.00202. eCollection 2017. Review.</citation>
    <PMID>29204425</PMID>
  </reference>
  <reference>
    <citation>Froehler MT, Chitale R, Magarik JA, Fusco MR. Comparison of a pressure-sensing sheath and radial arterial line for intraoperative blood pressure monitoring in neurointerventional procedures. J Neurointerv Surg. 2018 Aug;10(8):784-787. doi: 10.1136/neurintsurg-2018-013769. Epub 2018 Feb 27.</citation>
    <PMID>29487193</PMID>
  </reference>
  <reference>
    <citation>Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986 Feb 8;1(8476):307-10.</citation>
    <PMID>2868172</PMID>
  </reference>
  <reference>
    <citation>Martina JR, Westerhof BE, van Goudoever J, de Beaumont EM, Truijen J, Kim YS, Immink RV, Jöbsis DA, Hollmann MW, Lahpor JR, de Mol BA, van Lieshout JJ. Noninvasive continuous arterial blood pressure monitoring with Nexfin®. Anesthesiology. 2012 May;116(5):1092-103. doi: 10.1097/ALN.0b013e31824f94ed.</citation>
    <PMID>22415387</PMID>
  </reference>
  <reference>
    <citation>Gratz I, Deal E, Spitz F, Baruch M, Allen IE, Seaman JE, Pukenas E, Jean S. Continuous Non-invasive finger cuff CareTaker® comparable to invasive intra-arterial pressure in patients undergoing major intra-abdominal surgery. BMC Anesthesiol. 2017 Mar 21;17(1):48. doi: 10.1186/s12871-017-0337-z.</citation>
    <PMID>28327093</PMID>
  </reference>
  <reference>
    <citation>Hohn A, Defosse JM, Becker S, Steffen C, Wappler F, Sakka SG. Non-invasive continuous arterial pressure monitoring with Nexfin does not sufficiently replace invasive measurements in critically ill patients. Br J Anaesth. 2013 Aug;111(2):178-84. doi: 10.1093/bja/aet023. Epub 2013 Mar 13.</citation>
    <PMID>23485882</PMID>
  </reference>
  <reference>
    <citation>Kim SH, Lilot M, Sidhu KS, Rinehart J, Yu Z, Canales C, Cannesson M. Accuracy and precision of continuous noninvasive arterial pressure monitoring compared with invasive arterial pressure: a systematic review and meta-analysis. Anesthesiology. 2014 May;120(5):1080-97. doi: 10.1097/ALN.0000000000000226. Review.</citation>
    <PMID>24637618</PMID>
  </reference>
  <results_reference>
    <citation>Gerlach G, Hofer HW. Interaction of immobilized phosphofructokinase with soluble muscle proteins. Biochim Biophys Acta. 1986 May 2;881(3):398-404.</citation>
    <PMID>2938635</PMID>
  </results_reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 4, 2021</study_first_submitted>
  <study_first_submitted_qc>October 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 3, 2021</study_first_posted>
  <last_update_submitted>October 22, 2021</last_update_submitted>
  <last_update_submitted_qc>October 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-invasive blood pressure monitor</keyword>
  <keyword>arterial waveform</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>IPD (study protocol and analytic code) that underlines the results reported in a further publication article, after de-identification.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>The estimated study completion date is 2022-6-30. These supporting information would become available beginning 3 months and ending 5 years following article publication.</ipd_time_frame>
    <ipd_access_criteria>Researches who provide a methodologically sound proposal.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

